• Impact of PCV7 on Infections Caused by Antibiotic-resistant Streptococcus pneumoniae
  Ron Dagan, ISRAEL
• Antibiotic Resistance
  Jae-Hoon Song, SOUTH KOREA
• Is There Still a Need for the Prudent Use of Antibiotics in the PCV Era?
  Ron Dagan, ISRAEL
• Influenza and Pneumococcal Pneumonia
  Keith P. Klugman, USA
• The Future of Pneumococcal Disease Prevention
  Bernard Fritzell, FRANCE
  

Update in Emerging Infectious Diseases 2008
Friday, June 20, 2008, 12:30 - 14:15hrs, Room 302 & 303
Organized by ProMED-mail

• Viral Diseases
  Tom Yuill, USA
• Bacterial Diseases
  Larry Lutwick, USA
• Parasitic Diseases
  Eskild Petersen, DENMARK
• Zoonotic Diseases
  Arnon Shimshony, ISRAEL
• Mekong Basin Regional Update (PRO/MBDS)
  Marjorie Pollack, USA
• Mapping and Data Aggregation on Healthmap
  John Brownstein, USA
• Plant Disease Update and Why You Should Care
  Dagmar Hanold, AUSTRALIA
  

• Trends & Challenges in the Management of Infection in Immunocompromised Patients in Asia
  Christopher Lee, MALAYSIA
• Treatment of Aspergillosis: IDSA Clinical Practice Guidelines
  Thomas Patterson, USA
• Early Antifungal Treatment: Rationale & Advantages
  Monica Slavin, AUSTRALIA

• A Fully Liquid Pentavalent Vaccine: Clinical Experiences and Practical Benefits
  Angela Gentile, ARGENTINA
• From Drift to Shift: Broad Immunity with MF59^®-adjuvanted Influenza Vaccines
  Theodore Tsai, USA
• Comprehensive Protection Against Invasive Meningococcal Disease
  Terry Nolan, AUSTRALIA

• Evaluation of humoral immune function in the patient with recurrent infection
  Mimi Tang, AUSTRALIA
• Controversies in immunoglobulin replacement for immune deficiency
  Mimi Tang, AUSTRALIA

• The Responsible Use of Antimicrobials
  Ching Ching Wu, USA
• The Importance of Antimicrobials to Animal Health and Public Health
  Yong Ho Park, SOUTH KOREA

• Lessons Learned from the Spanish Flu in 1918
  Lance Jennings, NEW ZEALAND
• What Could be the Role of Pre-pandemic Vaccination in Today’s Preparedness Planning?
  Jonathan Van Tam, UNITED KINGDOM
• Vero Cell Technology and H5N1 Influenza Vaccines - An Unique Combination
  Noel Barrett, AUSTRIA
• Clinical Development of H5N1 Vaccines using Different Strains
  Greg Berezuk, USA

• Global Resistance Trends and the Potential Impact on Empirical Therapy
  Raul Isturiz, VENEZUELA
• What's New on the Antimicrobial Horizon?
  Jae-Hoon Song, SOUTH KOREA
• A Review of Tigecyline: The First Glycylcycline
  Lance R. Peterson, USA

• From Prompt Infant Protectionwith Infanrix to Routine Pertussis Boosters
  
• Optimizing Vaccination Strategy and Control of Varicella 
  
• Ready to Conquer Rotavirus Worldwide: A Vaccine with Demonstrated Global Efficacy
• New Asian Efficacy Data with Rotarix™